Icon (Close Menu)

Logout

TiFiber Receives ASTA Funding for Development of Antibacterial Treatment

1 min read

Fayetteville’s TiFiber has received a $75,000 investment from the Arkansas Science & Technology Authority for further development of an antibacterial treatment that could one day replace triclosan.

TiFiber, an Innovate Arkansas client firm and a portfolio firm of VIC Technology Venture Development, manufactures materials and products for control of dangerous or detrimental microorganisms.

It struck a deal this past spring with Bradford Soap Works, a global leader in the manufacturing of bar soaps, to commercialize synthetic, antimicrobial polymers that could replace triclosan, a controversial antibacterial agent.

TiFiber will use the ASTA investment to commercialize the technology, called TiAMP, and develop personal care products. The technology was developed at the University of Auckland in New Zealand, and has been proven to kill bacteria found in products including soaps, detergents, toys and surgical cleaning treatments.

ASTA is a state organization dedicated to the development, expansion and retention of high-paying, knowledge-based industries through high-tech entrepreneurship, research and STEM education.

Send this to a friend